Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 06 Apr 2023

Amino acid polymorphisms in human histocompatibility leukocyte antigen class II and proinsulin epitope have impacts on type 1 diabetes mellitus induced by immune-checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Hidefumi Inaba
Shuhei Morita
Daisuke Kosugi
Yuki Asai
Yosuke Kaido
Saya Ito
Tomonao Hirobata
Gen Inoue
Yuki Yamamoto
Masatoshi Jinnin

Frontiers in Immunology

doi 10.3389/fimmu.2023.1165004

3,588 views
9 citations

Original Research

Published on 06 Apr 2023

Prognostic value of various immune cells and Immunoscore in triple-negative breast cancer

in Cancer Immunity and Immunotherapy

Xinyu Ren
Yu Song
Junyi Pang
Longyun Chen
Liangrui Zhou
Zhiyong Liang
Huanwen Wu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1137561

4,212 views
13 citations

Original Research

Published on 06 Apr 2023

A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence

in Cancer Immunity and Immunotherapy

Sifei Yu
Mengdi Chen
Lili Xu
Enqiang Mao
Silei Sun

Frontiers in Immunology

doi 10.3389/fimmu.2023.1175490

18,887 views
36 citations

Review

Published on 06 Apr 2023

Role of CD147 in the development and diagnosis of hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Defa Huang
Dingyu Rao
Qing Jin
Mi Lai
Jiali Zhang
Zhonghong Lai
Haibin Shen
Tianyu Zhong

Frontiers in Immunology

doi 10.3389/fimmu.2023.1149931

7,320 views
24 citations

Original Research

Published on 06 Apr 2023

A novel molecular signature for predicting prognosis and immunotherapy response in osteosarcoma based on tumor-infiltrating cell marker genes

in Cancer Immunity and Immunotherapy

Haijun Tang
Shangyu Liu
Xiaoting Luo
Yu Sun
Xiangde Li
Kai Luo
Shijie Liao
Feicui Li
Jiming Liang
Xinli Zhan

Frontiers in Immunology

doi 10.3389/fimmu.2023.1150588

4,253 views
10 citations

Review

Published on 06 Apr 2023

Immunotherapy resistance in non-small-cell lung cancer: From mechanism to clinical strategies

in Cancer Immunity and Immunotherapy

Suna Zhou
Haihua Yang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1129465

20,169 views
46 citations

Original Research

Published on 05 Apr 2023

Machine learning-based integration develops an immune-related risk model for predicting prognosis of high-grade serous ovarian cancer and providing therapeutic strategies

in Cancer Immunity and Immunotherapy

Qihui Wu
Ruotong Tian
Xiaoyun He
Jiaxin Liu
Chunlin Ou
Yimin Li
Xiaodan Fu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1164408

5,237 views
6 citations

Original Research

Published on 05 Apr 2023

Bv8 mediates myeloid cell migration and enhances malignancy of colorectal cancer

in Cancer Immunity and Immunotherapy

Xiaomeng Li
Enqiang Chang
Jiang Cui
Hailin Zhao
Cong Hu
Kieran P. O’Dea
Nikhil Tirlapur
Gianfranco Balboni
Jiaqiang Zhang
Liming Ying

Frontiers in Immunology

doi 10.3389/fimmu.2023.1158045

4,095 views
4 citations

Editorial

Published on 04 Apr 2023

Editorial: The immune escape mechanism and novel immunotherapeutic strategies of leukemia

in Cancer Immunity and Immunotherapy

Kang Yu
Jialing Zhang
Qianping Li
Shenghui Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1188582

1,601 views
1 citation

Review

Published on 04 Apr 2023

NLRP3 inflammasome-induced pyroptosis in digestive system tumors

in Cancer Immunity and Immunotherapy

Jiexia Wen
Bin Xuan
Yang Liu
Liwei Wang
Li He
Xiangcai Meng
Tao Zhou
Yimin Wang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1074606

10,517 views
28 citations

Original Research

Published on 04 Apr 2023

Construction of a novel anoikis-related prognostic model and analysis of its correlation with infiltration of immune cells in neuroblastoma

in Cancer Immunity and Immunotherapy

Ji Chen
Mengjiao Sun
Chuqin Chen
Meiyun Kang
Bo Qian
Jing Sun
Xiaopeng Ma
Jianfeng Zhou
Lei Huang
Bin Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1135617

3,469 views
3 citations

Original Research

Published on 04 Apr 2023

Antitumor activity and safety of camrelizumab combined with apatinib in patients with relapsed or refractory peripheral T-cell lymphoma: An open-label, multicenter, phase II study

in Cancer Immunity and Immunotherapy

Yanfei Liu
Yuqin Song
Shubo Zuo
Xian Zhang
Hui Liu
Jingwen Wang
Jingbo Wang
Yongjing Tang
Wen Zheng
Zhitao Ying

Frontiers in Immunology

doi 10.3389/fimmu.2023.1128172

3,106 views
5 citations

Mini Review

Published on 04 Apr 2023

Immune-related pulmonary toxicities of checkpoint inhibitors in non-small cell lung cancer: Diagnosis, mechanism, and treatment strategies

in Cancer Immunity and Immunotherapy

Xinyu Guo
Shi Chen
Xueyan Wang
Xiaowei Liu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1138483

14,690 views
21 citations

Original Research

Published on 04 Apr 2023

Construction and validation of a T cell proliferation regulator-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Wuguang Chang
Hongmu Li
Yixin Cheng
Huanhuan He
Wei Ou
Si-Yu Wang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1171145

3,893 views

Original Research

Published on 04 Apr 2023

Integrating single-cell RNA-seq and spatial transcriptomics reveals MDK-NCL dependent immunosuppressive environment in endometrial carcinoma

in Cancer Immunity and Immunotherapy

Xinnian Yu
Linjun Xie
Jianjuan Ge
Huixin Li
Shanliang Zhong
Xiaolin Liu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1145300

34,179 views
50 citations

Original Research

Published on 04 Apr 2023

Generation of a symmetrical trispecific NK cell engager based on a two-in-one antibody

in Cancer Immunity and Immunotherapy

Julia Harwardt
Stefania C. Carrara
Jan P. Bogen
Katrin Schoenfeld
Julius Grzeschik
Björn Hock
Harald Kolmar

Frontiers in Immunology

doi 10.3389/fimmu.2023.1170042

11,875 views
8 citations